Nachrichten zur Acadia Pharmaceuticals Inc. Aktie

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.BERWYN, Pennsylvania --(BUSINESS WIRE)-- 18.12.2023 --Amring Pharmaceuticals…

Acadia Pharmaceuticals: Legal Overhang On Nuplazid Removed

…

Acadia Pharmaceuticals surges 32% after win in patent suit over Nuplazid

…

ACADIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Acadia Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ACADIA SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) and Encourages Long-Term ACAD Investors to Contact the Firm

PHILADELPHIA, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Acadia Pharmaceuticals Inc.…

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

CHARLOTTESVILLE, Va., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”),…

ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript

…

Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CHARLOTTESVILLE, Va., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stage…

Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CHARLOTTESVILLE, Va., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stage…

Acadia Pharmaceuticals stock surges 7% on JPMorgan upgrade By Investing.com

Acadia Pharmaceuticals stock surges 7% on JPMorgan upgrade…

Acadia Pharmaceuticals (ACAD) Q2 Earnings and Revenues Beat Estimates

Acadia (ACAD) delivered earnings and revenue surprises of 108.33% and 7.08%, respectively, for the quarter ended June 2023. Do the…

Form 8-K ACADIA PHARMACEUTICALS For: Aug 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is ACADIA Pharmaceuticals (ACAD) Stock Outpacing Its Medical Peers This Year?

Here is how Acadia Pharmaceuticals (ACAD) and Abbott (ABT) have performed compared to their sector so far this year....…

Insiderhandel: CEO verkauft Aktien von ACADIA Pharmaceuticals im Wert von 3.004.350$

Davis, Stephen - Vorstand - Tag der Transaktion: 2023-07-14...…

Form 8-K ACADIA PHARMACEUTICALS For: Jul 13

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Acadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here’s What to Expect.

Acadia Pharmaceuticals shares surged following the announcement of the companys acquisition of expanded commercial rights for a groundbreaking drug....…